Date:May 19, 2025
Join us in celebrating his impressive achievements and dedication to transforming the healthcare system across Africa.
Bio Usawa has a singular mission: to manufacture and commercialize high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond.
Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.
"Our new strategic partnership opens the door to providing effective, affordable high-quality monoclonal antibodies to patients in Sub-Saharan Africa su…
July 2025Bio Usawa Biotechnology Ltd. (Bio Usawa) and Bioeq AG today announced a groundbreaking agreement that will bring a life-changing biosimilar medicine—ran…
July 2025Dr. Menghis Bairu, CEO, Co-Founder and President of Bio Usawa (BUI), together with Dr. Miriam Mutebi, internationally recognized surgical oncologist and…
June 2025